期刊文献+

PPARs激动剂上调内皮细胞表达eNOS并增加NO生成 被引量:4

PPARs ligands antagonizes Ang-induced decrease in endothelial NO production by upregulating eNOS expression
下载PDF
导出
摘要 目的:观察PPARα激动剂非诺贝特及PPARγ激动剂赛格列酮对人脐静脉内皮细胞(HUVECs)血管紧张素Ⅱ(AngⅡ)抑制NO生成的作用。方法:体外培养HUVECs,用1×10-7-1×10-4mol/L赛格列酮和10-5、10-4mol/L非诺贝特预处理HUVECs 24 h,再与10-6mol/L AngⅡ共同孵育12 h,通过RT-PCR和Western blotting分别检测eNOS mRNA和蛋白表达水平;通过Griees反应测定NO2-/NO3-浓度。结果:与对照组相比,10-7mol/L AngⅡ刺激HUVEC 12 h下调eNOS mRNA(0.38±0.19vs0.13±0.18,P<0.01)和蛋白(35.90±3.18vs6.95±2.19,P<0.01)表达,减少NO生成(50.21μmol/Lvs21.33μmol/L,P<0.01)。用10-7、10-6、10-51、0-4mol/L赛格列酮预处理24 h,上调eNOS mRNA表达(分别为0.36±0.03、0.36±0.14、0.37±0.16、0.43±0.06,与AngⅡ组比较,均P<0.01)和蛋白表达(分别为11.60±3.31、11.78±5.45、13.93±2.46、22.93±3.17,与AngⅡ组相比,均P<0.01),增加细胞培养液NO2-/NO3-浓度。非诺贝特也上调eNOS mRNA和蛋白表达,增加细胞培养液NO2-/NO3-浓度(P<0.01)。结论:AngⅡ减少eNOS表达,从而减少NO生成。赛格列酮和非诺贝特预处理24 h,可拮抗AngⅡ对HUVECs eNOS mRNA和蛋白表达的抑制作用,增加NO的释放。 AIM: We hypothesized that PPART ligands stimulate endothelial - derived nitric oxide (NO) release to protect the vascular wall. Thus, the purpose of this study is to investigate the effects of ciglitazone (Cig) and fenofibrate (Fen) on angiotensin Ⅱ (AngⅡ) - induced decrease in endothelial NO synthase (eNOS) expression and NO production in human umbilical vein endothelial cells ( HUVECs ). METHODS: HUVECs were preincubated for 24 h with Cig ( 10^-7, 10^-6 ,10^-5, 10^-4 mol/L) or Fen ( 10^-5 and 10^-4 mol/L), then incubated for 12 h with 10^-7 mol/L Ang 11 . Total RNA was extracted, and the expression of mRNA and protein of eNOS was assessed by RT - PCR and Western blotting. NO production was measured by Griees method. RESULTS: In the presence of 10^-7 moL/L AngⅡ for 12 h, NO production in cultured HUVECs was decreased ( P 〈0.01). Cig and Fen pretreatments enhanced NO production ( P 〈 0.01 ) and antagonized Ang - induced decrease in eNOS mRNA and protein levels in HUVECs. CONCLUSION: PPART activator, eiglitazone, and PPARα activator, fenofibrate, antagonize Ang- induced decrease in endothelial NO production by directly upregulating eNOS expression.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2006年第5期911-914,共4页 Chinese Journal of Pathophysiology
基金 广东省自然科学基金资助课题(No.04009589) 广东省科技计划资助项目(No.2KM04703S)
关键词 过氧化物酶体增殖因子活化受体 赛格列酮 非诺贝特 一氧化氮合酶 一氧化氮 血管紧张素Ⅱ Peroxisome proliferator-activated receptors Ciglitazone Fenofibrate Nitric- oxide synthase Nitric oxide
  • 相关文献

参考文献12

  • 1Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction[J]. J Clin Invest, 1997, 100(9): 2153- 2157.
  • 2Goya K, Sumitani S, Xu X, et al. Peroxisome proliferator-activated receptor α agonists increase nitric oxide synthase expression in vascular endothelial cells [J]. Arterioscler Thromb Vasc Biol, 2004, 24(4): 658-663.
  • 3Calnek DS, Mazzella L, Roser S, et al. Peroxisome proliferator- activated receptor gamma ligands increase release of nitric oxide from endothelial cells[J]. Arterioscler Thromb Vasc Biol, 2003, 23(1): 52-57.
  • 4Polikandriotis JA, Mazzella LJ, Rupnow HL, et al. Peroxisome proliferator- activated receptor γ ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator- activated receptor γ- dependent mechanisms[J]. Arterioscler Thromb Vasc Biol, 2005, 25(9): 1810-1816.
  • 5Braissant O, Foufelle F, Scotto C, et al. Differential expression of peroxisome proliferators- activated receptors(PPARs) :tissue distribution of PPAR- alpha, - beta, and gamma in the adult rat[J]. Endocrinology, 1996, 137(1): 354-366.
  • 6Diabetes Atherosclerosis Intervention Study Inverstigators. Effect of fenofibrate on progression of coronary - artery disease in type 2 diabetes: the diabetes atherosclerosis intervention study, a randomised study[J]. Lancet, 2001, 357(9260):905 - 910.
  • 7Sidhu JS, Kaposzta Z, Mark, s HS, et al. Effect of rosiglitazone on common carotid intima- media thickness progression in coronary artery disease patients without diabetes mellitus[J].Arterioscler Thromb Vasc Biol, 2004, 24(5): 930-934.
  • 8刘世明,陈敏生,丁月霞,李昭骥.非诺贝特上调血管内皮细胞一氧化氮合酶的表达(英文)[J].中国病理生理杂志,2004,20(9):1621-1626. 被引量:2
  • 9Cho DH, Choi Y J, Jo SA, et al. Nitric oxide production and regulation of endothelial nitric - oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator- activated receptor (PPAR)gamma- dependent and PPAR gamma- independent signaling pathways[J]. J Biol Chem, 2004, 279(4): 2499- 2506.
  • 10Ruotolo G, Ericson CG, Tettamanti C, et al. Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)[J]. J Am Coll Cardiol, 1998, 32(6): 1648- 1656.

二级参考文献2

共引文献1

同被引文献33

  • 1杨文英.从脂毒性到糖尿病再到血脂异常[J].国外医学(内分泌学分册),2004,24(4):287-288. 被引量:65
  • 2朱惠莲,唐志红,夏敏,马静,凌文华.LOX-1介导ox-LDL诱导的血管内皮细胞MCP-1的表达[J].中国病理生理杂志,2005,21(7):1249-1254. 被引量:8
  • 3朱惠莲,夏敏,侯孟君,唐志红,郑佩英,凌文华.氧化低密度脂蛋白通过血凝素样氧化低密度脂蛋白受体1诱导血管内皮细胞粘附分子的表达[J].中华心血管病杂志,2005,33(8):743-747. 被引量:8
  • 4Mohanty P, Aljada A, Ghanim H, et al. Rosiglitazone improves vascular reactivity, inhibits reactive oxygen species (ROS) generation, reduce subunit expression in mononuclear cells ( MNC ) and reduce C reactive protein(CRP) and monocyte chemotactic protein 21 ( MCP21 ) : evidence of potent inflammatory effect [J]. Diabetes,2001 ;50 ( 2 ) : A68.
  • 5Rizos CV, Liberopoulos EN, Mikhailidis DP, Elisaf MSo Pleiotropic effects of thiazolidinediones. Expert Opin Pharmacother, 2008 ; 9 ( 7 ) : 1087-108.
  • 6Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction[J]. J Clin Invest, 1997 ; 100 (9) :2153-7.
  • 7Jozkowicz A, Nigisch A, Winter B, et al. 15-deoxy-delta12,14-prostaglandin-J2 inhibits expression of eNOS in human endothelial cells [J]. Prostaglandins Other Lipid Mediat, 2004 ;74 ( 1 4 ) : 11-28.
  • 8Gonon AT, Bulhak A, Labruto F, et al. Cardioproteetion mediated by rosiglitazone, a peroxisome proliferator-aetivated receptor gamma ligand, in relation to nitric oxide[J]. Basic Res Cardiol, 2007;102( 1 ) :80-9.
  • 9Hwang J, Lee HI, Chang YS, et al. 15-deoxy-Deha12,14-prostaglandin J2-induced down-regulation of endothelial nitric oxide synthase in association with HSP70 induction[J], 2007 ;357 ( 1 ) :206-11.
  • 10Hsueh WA,Law RE. Insulin signaling in the arterial wall[J]. Am J Cardiol, 1999 ;84:21-24.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部